UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 45,000 shares of the firm's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $13.11, for a total transaction of $589,950.00. Following the completion of the sale, the chief executive officer owned 5,373,376 shares of the company's stock, valued at $70,444,959.36. This trade represents a 0.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Daniel Dines also recently made the following trade(s):
- On Wednesday, July 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.54, for a total value of $564,300.00.
- On Monday, June 30th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.78, for a total transaction of $575,100.00.
- On Friday, June 27th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.78, for a total transaction of $575,100.00.
- On Wednesday, June 25th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $12.55, for a total transaction of $564,750.00.
- On Monday, June 23rd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $12.10, for a total transaction of $544,500.00.
UiPath Stock Up 0.5%
Shares of PATH stock traded up $0.06 during trading hours on Tuesday, hitting $13.22. 7,180,697 shares of the company were exchanged, compared to its average volume of 10,402,867. The firm has a fifty day moving average of $12.63 and a 200 day moving average of $12.46. UiPath, Inc. has a 1 year low of $9.38 and a 1 year high of $15.93. The firm has a market cap of $7.07 billion, a PE ratio of -110.16, a PEG ratio of 17.41 and a beta of 1.04.
UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The company had revenue of $356.62 million for the quarter, compared to analyst estimates of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. UiPath's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the business earned $0.13 EPS. Analysts expect that UiPath, Inc. will post -0.17 earnings per share for the current year.
Hedge Funds Weigh In On UiPath
A number of large investors have recently modified their holdings of the company. Tidal Investments LLC raised its holdings in UiPath by 3.7% in the fourth quarter. Tidal Investments LLC now owns 22,487 shares of the company's stock valued at $286,000 after buying an additional 797 shares during the period. True Wealth Design LLC raised its stake in shares of UiPath by 18.4% in the 4th quarter. True Wealth Design LLC now owns 5,163 shares of the company's stock valued at $66,000 after acquiring an additional 801 shares during the period. United Capital Financial Advisors LLC lifted its holdings in shares of UiPath by 8.6% during the 4th quarter. United Capital Financial Advisors LLC now owns 12,238 shares of the company's stock valued at $156,000 after acquiring an additional 971 shares in the last quarter. NewEdge Advisors LLC boosted its position in UiPath by 6.8% during the 4th quarter. NewEdge Advisors LLC now owns 15,809 shares of the company's stock worth $201,000 after purchasing an additional 1,003 shares during the period. Finally, Xponance Inc. increased its holdings in UiPath by 2.0% in the 1st quarter. Xponance Inc. now owns 54,246 shares of the company's stock valued at $559,000 after purchasing an additional 1,054 shares in the last quarter. 62.50% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
PATH has been the subject of several research analyst reports. Bank of America reaffirmed an "underperform" rating and issued a $10.00 price objective (down from $18.00) on shares of UiPath in a research note on Thursday, March 13th. Barclays reaffirmed an "equal weight" rating on shares of UiPath in a research note on Friday, May 30th. Mizuho lowered their price objective on shares of UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. UBS Group dropped their target price on shares of UiPath from $14.00 to $10.00 and set a "sell" rating for the company in a report on Thursday, March 13th. Finally, Morgan Stanley upped their price target on shares of UiPath from $12.00 to $15.00 and gave the company an "equal weight" rating in a report on Monday, June 2nd. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $13.83.
Get Our Latest Analysis on PATH
About UiPath
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.